Moogene Medi Co., Ltd. (XKON:322970)
South Korea · Delayed Price · Currency is KRW 2,165.00
+40.00 (1.88%)
At close: Mar 5, 2026
Moogene Medi Company Description
Moogene Medi Co., Ltd. develops nanobiotechnology-based drug delivery systems.
It develops lipid nanoparticle (LNP) materials for pharmaceutical protein delivery; RNP (sgRNA+ CRISPR Cas9)-encapsulated LNP for gene therapy; novel therapy for colorectal or pancreatic cancer with anticancer drug resistance due to genetic mutation by using RNP-encapsulated LNP; and topical treatment for androgenic alopecia therapy.
The company was founded in 2016 and is headquartered in Hanam-si, South Korea.
Moogene Medi Co., Ltd.
| Country | South Korea |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: Building C Hanam-si, 12939 South Korea | |
| Phone | 82 31 8027 6150 |
| Website | moogene.com |
Stock Details
| Ticker Symbol | 322970 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |